Mounjaro

Mounjaro® is a prescription medication approved by the FDA to help adults with type 2 diabetes improve their blood sugar control, but may be prescribed off-label for weight loss, if appropriate. Zepbound®, another tirzepatide-containing medication, is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or in adults who are overweight (BMI ≥27) and have at least one weight-related medical condition.

Both products contain the same active ingredient, tirzepatide, and are offered in comparable dosing strengths. Your healthcare provider will determine whether tirzepatide is appropriate based on your individual health needs and the FDA-approved indications.

Mounjaro® is taken as a once-weekly injection under the skin. It can be administered at any time of day, with or without food, and is usually incorporated into a consistent weekly routine. Your healthcare provider determines dosing and adjustments based on your response and tolerance.

• Injected under the skin (abdomen, thigh, or upper arm)
• Taken once per week on a consistent schedule
• Can be used with or without meals
• Injection sites should be rotated regularly
• Dose adjustments are guided by a healthcare provider

Mounjaro® can cause side effects, most commonly affecting the digestive system. These effects are similar whether the medication is used for its approved indication or prescribed off-label. Patients should also be aware of serious risks and seek medical attention if concerning symptoms occur.

• Common: nausea, diarrhea, vomiting, constipation, decreased appetite
• Other possible: abdominal discomfort or indigestion
• Risk of low blood sugar increases when combined with certain diabetes medications
• Seek urgent care for severe abdominal pain (possible pancreatitis)
• Contact a provider immediately for symptoms like neck swelling or difficulty swallowing (thyroid tumor warning)

For full safety information see full Important Safety Information

Mounjaro® can be taken with or without food. Because it is injected under the skin rather than taken by mouth, meals do not affect how it is administered. Choosing a consistent weekly time that fits your routine can help you stay on track.

• No requirement to coordinate with meals
• Can be taken at any time of day
• Consistency week to week is most important
• Adjust timing if needed with provider guidance

If you miss a dose, timing matters. In some cases, you may still be able to take the dose within a certain window, but if too much time has passed, you should skip it and continue your regular schedule.

• Take the missed dose if within the allowed time window
• Skip it if the next scheduled dose is too close
• Do not take two doses at the same time
• Resume your regular weekly schedule

For exact instructions, follow your provider’s guidance or the Medication Guide.

Yes, the dosing day can be changed if needed, but spacing between doses must be maintained. This helps reduce the risk of taking doses too close together.

• Ensure enough time between doses before switching
• Choose a new consistent weekly day
• Avoid overlapping doses
• Confirm changes with your provider if unsure

If your schedule changes, your provider can guide you on how to adjust safely.

Mounjaro® is injected under the skin in specific areas of the body. Rotating injection sites helps reduce irritation and supports proper absorption over time.

• Common injection areas include abdomen, thigh, or upper arm
• Rotate injection sites each week
• Avoid irritated, bruised, or scarred skin
• Use a different spot within the same area if needed

Mounjaro® can be used with other diabetes medications, but combining treatments may increase the risk of low blood sugar. Your provider may adjust your treatment plan to help manage this risk.

• Higher risk of low blood sugar with insulin or sulfonylureas
• Dose adjustments may be required
• Monitor for symptoms like dizziness or sweating
• Keep your provider informed about all medications

Always follow your provider’s instructions and report symptoms promptly.

Mounjaro® may affect how oral birth control pills are absorbed, particularly when starting treatment or increasing the dose. This could reduce effectiveness.

• Consider a non-oral contraceptive option
• Or use a barrier method for additional protection
• Discuss timing and options with your provider

Your provider can help you choose a safe and effective approach.

Proper storage helps maintain the medication’s quality. Planning ahead is important, especially when traveling.

• Store in the refrigerator and protect from light
• Do not freeze
• Keep in original packaging
• Follow instructions for temporary room temperature storage

If traveling, use a temperature-controlled method to keep it within recommended conditions.

Mounjaro® should only be used if it has been stored correctly and appears normal. Improper storage may affect safety or effectiveness.

• Do not use if frozen
• Avoid use if exposed to improper temperatures
• Do not use if the solution is cloudy or discolored
• Ask your pharmacist or provider if unsure

When in doubt, it is safer to replace the medication.

Mounjaro® is not specifically labeled as impairing driving, but certain side effects or low blood sugar may affect alertness. It is important to understand how your body responds.

• Be cautious if you feel dizzy or unwell
• Low blood sugar can affect concentration
• Monitor your response when starting or adjusting treatment
• Avoid driving if you are not fully alert

There is no specific instruction in the prescribing information regarding alcohol use. However, alcohol can affect blood sugar levels and may influence your overall treatment plan.

• Alcohol may increase risk of blood sugar fluctuations
• Effects vary depending on timing and amount
• Monitor your body’s response carefully

It’s best to discuss alcohol use with your provider to ensure safe integration into your care plan.

Accessing Mounjaro® through US Quick Health typically involves an online medical evaluation. A licensed provider reviews your health information and determines whether treatment is appropriate.

• Complete an online consultation or questionnaire
• Provider assesses your eligibility
• Prescription is issued if appropriate
• Medication is sent through a pharmacy

Mounjaro® (tirzepatide) Prescribing Information - official FDA-approved labeling including warnings, dosing, and safety details. / Source: FDA Link: https://pi.lilly.com/us/mounjaro-uspi.pdf / Published: May 13, 2022

MOUNJARO (tirzepatide) injection, solution - full drug label with contraindications, warnings, and medication guide. / Source: DailyMed (NIH) Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0 / Published: May 13, 2022